(lp0
S"Emergent BioSolutions Inc Sets Its Goal Motley Fool - Feb 24, 2017 Emergent BioSolutions  released fourth-quarter earnings on Thursday. The company announced preliminary numbers in January so it could talk about the results at the JP Morgan Healthcare conference, but the actual numbers were slightly better&nbsp;...What are analysts saying about Emergent BioSolutions Inc's  future? - Simply Wall St"
p1
aS'Why Emergent BioSolutions Inc. Procured a Lower Price Today Motley Fool - Jun 22, 2016 What: Emergent BioSolutions  is down 19% at 2:40 p.m. EDT after announcing that the U.S. Department of Health and Human Services  issued solicitation notices to buy more of its BioThrax anthrax vaccine and potentially NuThrax,&nbsp;...'
p2
aS'Why Emergent Biosolutions Inc. Stockpiled a Higher Price Today Motley Fool - Dec 9, 2016 Emergent BioSolutions  is up 19.5% at 3:02 p.m. EST, after announcing a new contract with the Centers for Disease Control and Prevention  and a separate deal with the Biomedical Advanced Research and Development Authority&nbsp;...'
p3
aS'Emergent BioSolutions Inc. Expanding Along Motley Fool - Mar 7, 2016 Emergent BioSolutions  released fourth-quarter earnings last week. With sales of BioThrax to the government firing along, investors should be focused on increasing manufacturing of BioThrax and the spinoff of its biosciences business, Aptevo&nbsp;...'
p4
aS"Emergent Biosolutions Inc Slimmed Down, Waiting on Contract Motley Fool - Nov 10, 2016 The FDA signed off on Emergent BioSolutions' new larger manufacturing plant for BioThrax, dubbed Building 55. But it's still unknown how much product made in the new building will still be sold to the U.S."
p5
aS"Emergent BioSolutions Inc in Transition Motley Fool - May 13, 2016 Emergent BioSolutions  released solid first-quarter results last week. The next few quarters are up in the air due to the transition of the company's biodefense contract with the government, but management seems unfazed about Emergent's&nbsp;..."
p6
aS'Why Emergent Biosolutions Inc Surged Higher Today Motley Fool - Sep 30, 2016 Emergent Biosolutions  is up almost 14% at 3:27 p.m. EDT Friday after announcing that the company was given a multi-year contract from the Biomedical Advanced Research and Development Authority  to develop a next-generation&nbsp;...Emergent BioSolutions Awarded BARDA Contract for Advanced Development and ... - GlobeNewswire '
p7
aS"Emergent BioSolutions Inc. Asks for Patience Motley Fool - Aug 11, 2016 The CDC has already announced that Emergent BioSolutions will be the sole source for anthrax vaccine for the government's reserve under the next contract."
p8
aS"Emergent BioSolutions Is Oversold Forbes - Jun 27, 2016 Valuation Attractive; Reiterating 'Buy'. On June 22, shares of Emergent BioSolutions Inc. , plummeted 20% to close at $31.33."
p9
aS"Investor sues Emergent BioSolutions over demand for anthrax vaccine Washington Business Journal - Jul 20, 2016 An investor filed suit Tuesday against Gaithersburg-based Emergent BioSolutions Inc. and some of its executives, claiming the company oversold shareholders on the demand for its anthrax vaccine BioThrax, the company's biggest revenue generator.Safirstein Metcalf LLP Announces That a Class Action Lawsuit Has Been Filed ... - GlobeNewswire Emergent BioSolutions  Says Aptevo  Will Begin Trading on 'When ... - StreetInsider.com"
p10
a.